Kyongbo Pharmaceutical Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) and finished drugs in South Korea and internationally. Its offerings include general, cephalosporin, and anti-cancer APIs; prescription drugs such as anesthetics, cardiovascular, digestive, and antibiotic products; and OTC drugs. The company also provides medical devices, including portable X-ray machines, ultrasonic diagnostic equipment, extracorporeal shockwave therapy devices, and temperature control probes, and is engaged in CDMO business and R&D of Clopidogrel, Imatinib, Donepezil, Entecavir, and Esomeprazole. It exports its products, was formerly known as Kyongbo Chemical Co. Ltd., changed its name to Kyongbo Pharmaceutical Co., Ltd. in March 2002, was founded in 1987, and is headquartered in Asan-si, South Korea.